Synthetic data has recently reached a level of visual fidelity that makes it nearly indistinguishable from real data, offering great promise for privacy-preserving data sharing in medical imaging. However, fully synthetic datasets still suffer from significant limitations: First and foremost, the legal aspect of sharing synthetic data is often neglected and data regulations, such as the GDPR, are largley ignored. Secondly, synthetic models fall short of matching the performance of real data, even for in-domain downstream applications. Recent methods for image generation have focused on maximising image diversity instead of fidelity solely to improve the mode coverage and therefore the downstream performance of synthetic data. In this work, we shift perspective and highlight how maximizing diversity can also be interpreted as protecting natural persons from being singled out, which leads to predicate singling-out (PSO) secure synthetic datasets. Specifically, we propose a generalisable framework for training diffusion models on personal data which leads to unpersonal synthetic datasets achieving performance within one percentage point of real-data models while significantly outperforming state-of-the-art methods that do not ensure privacy. Our code is available at https://github.com/MischaD/Trichotomy.

The increasing use of diffusion models for image generation, especially in sensitive areas like medical imaging, has raised significant privacy concerns. Membership Inference Attack (MIA) has emerged as a potential approach to determine if a specific image was used to train a diffusion model, thus quantifying privacy risks. Existing MIA methods often rely on diffusion reconstruction errors, where member images are expected to have lower reconstruction errors than non-member images. However, applying these methods directly to medical images faces challenges. Reconstruction error is influenced by inherent image difficulty, and diffusion models struggle with high-frequency detail reconstruction. To address these issues, we propose a Frequency-Calibrated Reconstruction Error (FCRE) method for MIAs on medical image diffusion models. By focusing on reconstruction errors within a specific mid-frequency range and excluding both high-frequency (difficult to reconstruct) and low-frequency (less informative) regions, our frequency-selective approach mitigates the confounding factor of inherent image difficulty. Specifically, we analyze the reverse diffusion process, obtain the mid-frequency reconstruction error, and compute the structural similarity index score between the reconstructed and original images. Membership is determined by comparing this score to a threshold. Experiments on several medical image datasets demonstrate that our FCRE method outperforms existing MIA methods.

Explainability features are intended to provide insight into the internal mechanisms of an AI device, but there is a lack of evaluation techniques for assessing the quality of provided explanations. We propose a framework to assess and report explainable AI features. Our evaluation framework for AI explainability is based on four criteria: 1) Consistency quantifies the variability of explanations to similar inputs, 2) Plausibility estimates how close the explanation is to the ground truth, 3) Fidelity assesses the alignment between the explanation and the model internal mechanisms, and 4) Usefulness evaluates the impact on task performance of the explanation. Finally, we developed a scorecard for AI explainability methods that serves as a complete description and evaluation to accompany this type of algorithm. We describe these four criteria and give examples on how they can be evaluated. As a case study, we use Ablation CAM and Eigen CAM to illustrate the evaluation of explanation heatmaps on the detection of breast lesions on synthetic mammographies. The first three criteria are evaluated for clinically-relevant scenarios. Our proposed framework establishes criteria through which the quality of explanations provided by AI models can be evaluated. We intend for our framework to spark a dialogue regarding the value provided by explainability features and help improve the development and evaluation of AI-based medical devices.

Deep learning models have shown remarkable success in dermatological image analysis, offering potential for automated skin disease diagnosis. Previously, convolutional neural network(CNN) based architectures have achieved immense popularity and success in computer vision (CV) based task like skin image recognition, generation and video analysis. But with the emergence of transformer based models, CV tasks are now are nowadays carrying out using these models. Vision Transformers (ViTs) is such a transformer-based models that have shown success in computer vision. It uses self-attention mechanisms to achieve state-of-the-art performance across various tasks. However, their reliance on global attention mechanisms makes them susceptible to adversarial perturbations. This paper aims to investigate the susceptibility of ViTs for medical images to adversarial watermarking-a method that adds so-called imperceptible perturbations in order to fool models. By generating adversarial watermarks through Projected Gradient Descent (PGD), we examine the transferability of such attacks to CNNs and analyze the performance defense mechanism -- adversarial training. Results indicate that while performance is not compromised for clean images, ViTs certainly become much more vulnerable to adversarial attacks: an accuracy drop of as low as 27.6%. Nevertheless, adversarial training raises it up to 90.0%.

Over the past decade, Medical Image Segmentation (MIS) using Deep Neural Networks (DNNs) has achieved significant performance improvements and holds great promise for future developments. This paper presents a comprehensive study on MIS based on DNNs. Intelligent Vision Systems are often evaluated based on their output levels, such as Data, Information, Knowledge, Intelligence, and Wisdom (DIKIW),and the state-of-the-art solutions in MIS at these levels are the focus of research. Additionally, Explainable Artificial Intelligence (XAI) has become an important research direction, as it aims to uncover the "black box" nature of previous DNN architectures to meet the requirements of transparency and ethics. The study emphasizes the importance of MIS in disease diagnosis and early detection, particularly for increasing the survival rate of cancer patients through timely diagnosis. XAI and early prediction are considered two important steps in the journey from "intelligence" to "wisdom." Additionally, the paper addresses existing challenges and proposes potential solutions to enhance the efficiency of implementing DNN-based MIS.

Recent advancements in artificial intelligence (AI) have revolutionized cardiovascular medicine, particularly through integration with computed tomography (CT), magnetic resonance imaging (MRI), electrocardiography (ECG) and ultrasound (US). Deep learning architectures, including convolutional neural networks and generative adversarial networks, enable automated analysis of medical imaging and physiological signals, surpassing human capabilities in diagnostic accuracy and workflow efficiency. However, critical challenges persist, including the inability to validate input data accuracy, which may propagate diagnostic errors. This review highlights AI's transformative potential in precision diagnostics while underscoring the need for robust validation protocols to ensure clinical reliability. Future directions emphasize hybrid models integrating multimodal data and adaptive algorithms to refine personalized cardiovascular care.

The present study performs a comprehensive fairness analysis of machine learning (ML) models for the diagnosis of Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD) from MRI-derived neuroimaging features. Biases associated with age, race, and gender in a multi-cohort dataset, as well as the influence of proxy features encoding these sensitive attributes, are investigated. The reliability of various fairness definitions and metrics in the identification of such biases is also assessed. Based on the most appropriate fairness measures, a comparative analysis of widely used pre-processing, in-processing, and post-processing bias mitigation strategies is performed. Moreover, a novel composite measure is introduced to quantify the trade-off between fairness and performance by considering the F1-score and the equalized odds ratio, making it appropriate for medical diagnostic applications. The obtained results reveal the existence of biases related to age and race, while no significant gender bias is observed. The deployed mitigation strategies yield varying improvements in terms of fairness across the different sensitive attributes and studied subproblems. For race and gender, Reject Option Classification improves equalized odds by 46% and 57%, respectively, and achieves harmonic mean scores of 0.75 and 0.80 in the MCI versus AD subproblem, whereas for age, in the same subproblem, adversarial debiasing yields the highest equalized odds improvement of 40% with a harmonic mean score of 0.69. Insights are provided into how variations in AD neuropathology and risk factors, associated with demographic characteristics, influence model fairness.

Multi-modal medical image fusion (MMIF) is increasingly recognized as an essential technique for enhancing diagnostic precision and facilitating effective clinical decision-making within computer-aided diagnosis systems. MMIF combines data from X-ray, MRI, CT, PET, SPECT, and ultrasound to create detailed, clinically useful images of patient anatomy and pathology. These integrated representations significantly advance diagnostic accuracy, lesion detection, and segmentation. This comprehensive review meticulously surveys the evolution, methodologies, algorithms, current advancements, and clinical applications of MMIF. We present a critical comparative analysis of traditional fusion approaches, including pixel-, feature-, and decision-level methods, and delves into recent advancements driven by deep learning, generative models, and transformer-based architectures. A critical comparative analysis is presented between these conventional methods and contemporary techniques, highlighting differences in robustness, computational efficiency, and interpretability. The article addresses extensive clinical applications across oncology, neurology, and cardiology, demonstrating MMIF's vital role in precision medicine through improved patient-specific therapeutic outcomes. Moreover, the review thoroughly investigates the persistent challenges affecting MMIF's broad adoption, including issues related to data privacy, heterogeneity, computational complexity, interpretability of AI-driven algorithms, and integration within clinical workflows. It also identifies significant future research avenues, such as the integration of explainable AI, adoption of privacy-preserving federated learning frameworks, development of real-time fusion systems, and standardization efforts for regulatory compliance.

Deep neural networks excel in medical imaging but remain prone to biases, leading to fairness gaps across demographic groups. We provide the first systematic exploration of Human-AI alignment and fairness in this domain. Our results show that incorporating human insights consistently reduces fairness gaps and enhances out-of-domain generalization, though excessive alignment can introduce performance trade-offs, emphasizing the need for calibrated strategies. These findings highlight Human-AI alignment as a promising approach for developing fair, robust, and generalizable medical AI systems, striking a balance between expert guidance and automated efficiency. Our code is available at https://github.com/Roypic/Aligner.

Deep learning models have shown promise in lung pathology detection from chest X-rays, but widespread clinical adoption remains limited due to opaque model decision-making. In prior work, we introduced ClinicXAI, a human-centric, expert-guided concept bottleneck model (CBM) designed for interpretable lung cancer diagnosis. We now extend that approach and present XpertXAI, a generalizable expert-driven model that preserves human-interpretable clinical concepts while scaling to detect multiple lung pathologies. Using a high-performing InceptionV3-based classifier and a public dataset of chest X-rays with radiology reports, we compare XpertXAI against leading post-hoc explainability methods and an unsupervised CBM, XCBs. We assess explanations through comparison with expert radiologist annotations and medical ground truth. Although XpertXAI is trained for multiple pathologies, our expert validation focuses on lung cancer. We find that existing techniques frequently fail to produce clinically meaningful explanations, omitting key diagnostic features and disagreeing with radiologist judgments. XpertXAI not only outperforms these baselines in predictive accuracy but also delivers concept-level explanations that better align with expert reasoning. While our focus remains on explainability in lung cancer detection, this work illustrates how human-centric model design can be effectively extended to broader diagnostic contexts - offering a scalable path toward clinically meaningful explainable AI in medical diagnostics.